For informational purposes only — not investment advice

← Back to signals

DCH

Dauch Corporation

Research: Finviz ↗·Perplexity ↗

No convergence signal this quarter — shown because tracked funds have filed 13D/G on this stock.

Days to cover (short int.)
7.6d↓-10.1%
as of 2026-09-15

News Summary

Positive

Dauch Corporation delivered a strong Q2 2026 earnings beat (adjusted EPS of $0.32 vs. $0.16 consensus) and raised full-year revenue guidance to $10.6B–$10.8B, driven by successful integration of the Dowlais acquisition completed earlier in 2026. The company has doubled in size with improved portfolio diversification, synergy realization ahead of plan, and positive analyst sentiment (RBC raised price target to $11, reaffirmed Buy), though the business carries elevated debt from the acquisition and near-term production headwinds.

Fund 13D/13G Filings (1)

Tracked funds' beneficial-ownership filings on this stock — disclosed within days of a position change, fresher than the quarterly 13F. Since Filing compares the stock to SPY from the filing date (shown for filings within the last 90 days).

FundForm∆ Shares% of ClassSince FilingFiledSrc
Greenlight CapitalSC 13GNEW5.2%
-16.1% vs SPY
-16.1% abs
2026-08-14↗